tiprankstipranks
Advertisement
Advertisement

LGND Stock Latest News

Ligand price target raised to $252 from $235 at RBC Capital
The FlyLigand price target raised to $252 from $235 at RBC Capital
2d ago
LGND
Analyst Reiterates Buy on Ligand, Lifts Price Target to $260 on Royalty Portfolio Expansion from XOMA Acquisition
PremiumRatings
Analyst Reiterates Buy on Ligand, Lifts Price Target to $260 on Royalty Portfolio Expansion from XOMA Acquisition
2d ago
LGND
Ligand price target raised to $255 from $230 at Stifel
PremiumThe Fly
Ligand price target raised to $255 from $230 at Stifel
2d ago
LGND
XOMA
Ligand price target raised to $260 from $250 at BofA
PremiumThe Fly
Ligand price target raised to $260 from $250 at BofA
2d ago
LGND
XOMA
Ligand Pharma to Acquire XOMA, Expands Royalty Portfolio
PremiumCompany Announcements
Ligand Pharma to Acquire XOMA, Expands Royalty Portfolio
3d ago
8K
LGND
Morning Movers: Domino’s Pizza sinks following first quarter results
PremiumThe FlyMorning Movers: Domino’s Pizza sinks following first quarter results
3d ago
VZ
CPB
Ligand to acquire Xoma for $39.00 per share in cash
Premium
The Fly
Ligand to acquire Xoma for $39.00 per share in cash
3d ago
LGND
XOMA
Ligand to buy Xoma for $39 per share, WSJ reports
Premium
The Fly
Ligand to buy Xoma for $39 per share, WSJ reports
3d ago
LGND
XOMA
Ligand price target raised to $282 from $276 at Citi
PremiumThe Fly
Ligand price target raised to $282 from $276 at Citi
15d ago
LGND
Ligand price target raised to $243 from $239 at H.C. Wainwright
PremiumThe Fly
Ligand price target raised to $243 from $239 at H.C. Wainwright
16d ago
LGND
TVTX
This Is Why Travere Therapeutics Stock (TVTX) Surged Today
PremiumMarket News
This Is Why Travere Therapeutics Stock (TVTX) Surged Today
16d ago
LGND
TVTX
Ligand price target raised to $250 from $244 at BofA
PremiumThe Fly
Ligand price target raised to $250 from $244 at BofA
16d ago
LGND
TVTX
Ligand partner Travere Therapeutics announces FDA approval for Filspari
PremiumThe FlyLigand partner Travere Therapeutics announces FDA approval for Filspari
16d ago
LGND
TVTX
Citi ups Ligand target, opens ‘upside 90-day catalyst watch’
Premium
The Fly
Citi ups Ligand target, opens ‘upside 90-day catalyst watch’
1M ago
LGND
Oracle, Nike upgraded: Wall Street’s top analyst calls
Premium
The Fly
Oracle, Nike upgraded: Wall Street’s top analyst calls
2M ago
HAS
HOG
Ligand initiated with a Buy at BofA
PremiumThe Fly
Ligand initiated with a Buy at BofA
2M ago
LGND
Ligand files automatic mixed securities shelf
PremiumThe Fly
Ligand files automatic mixed securities shelf
2M ago
LGND
Ligand price target raised to $277 from $275 at Oppenheimer
PremiumThe Fly
Ligand price target raised to $277 from $275 at Oppenheimer
2M ago
LGND
Ligand sees FY26 EPS $8-$9, consensus $8.42
PremiumThe Fly
Ligand sees FY26 EPS $8-$9, consensus $8.42
2M ago
LGND
Ligand reports Q4 core EPS $2.02, consensus $1.50
PremiumThe FlyLigand reports Q4 core EPS $2.02, consensus $1.50
2M ago
LGND
Ligand price target raised to $239 from $231 at H.C. Wainwright
Premium
The Fly
Ligand price target raised to $239 from $231 at H.C. Wainwright
2M ago
LGND
PVLA
Is LGND a Buy, Before Earnings?
Premium
Pre-Earnings
Is LGND a Buy, Before Earnings?
2M ago
LGND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >